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ABSTRACT
We present the clinical case of a 76-year-old woman with delirium caused 
by multiple factors, including pneumonia. Although this type of case is quite 
common in clinical practice, it provides us with an opportunity to discuss 
laboratory testing in this context, with a special focus on the role of C-reactive 
protein (CRP). We present data regarding the requests for determination of 
serum CRP levels at the University of São Paulo University Hospital over 
the past few years. We also present a review of the medical literature on the 
topic, as well as clinical epidemiology concepts related to the impact that CRP 
testing has on the medical decision-making process.
Keywords: C-reactive protein; Internal medicine; Diagnostic techniques and procedures. 
INTRODUCTION
The objective of the present case report is 
to describe a common situation in the treatment of 
patients with acute community-acquired infections 
at a university hospital. We also present a critical 
evaluation of the ordering and interpretation of the 
results of tests to determine serum levels of C-reactive 
protein (CRP) as an inflammatory marker in this 
context. 
METHODS
We selected the case of a patient treated at the 
University of São Paulo University Hospital (USPUH) 
Emergency Department, located in the city of São 
Paulo, Brazil. We performed a retrospective analysis 
of the medical chart of the patient in an attempt to 
determine whether the determination of serum CRP 
levels was necessary for the management of the case. 
The present case report was approved by the 
local research ethics committee. 
CLINICAL CASE
A 76-year-old woman sought treatment in 
the USPUH Emergency Department with a 3-day 
history of hypoactivity and loss of appetite. The 
patient reported that she had experienced a drop in 
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the level of consciousness on the previous day. She 
also reported that she had fallen from standing height 
15 days prior to the onset of the symptoms. 
The patient had a personal history of chronic 
obstructive pulmonary disease and had been on home 
oxygen therapy for the last six years. She reported 
that she did not have arterial hypertension or diabetes 
and had experienced no cardiovascular events. The 
patient had a family history of cancer, her father 
having died at age 52 years from carcinoma of the 
oropharynx and her mother having died from cancer, 
the primary site of which was unknown to the patient. 
Physical examination revealed dehydration, 
pallor, cyanosis, and extensive ecchymosis on the 
right side of the face. The patient presented with 
spatiotemporal disorientation (Glasgow coma scale 
score, 13). Her temperature was 36 °C, her blood 
pressure was 90/50 mmHg, her heart rate was 
90 bpm, and her peripheral oxygen saturation was 
68% on room air. There were no signs or symptoms of 
heart disease, lung disease, or abdominal disease. In 
addition, there were no signs or symptoms of upper- 
or lower-limb disorders. Her capillary blood glucose 
level was 80 mg.dL–1. 
A presumptive diagnosis of hypoactive delirium 
was made, and tests were ordered (Table 1). A bedside 
chest X-ray was taken. Although it is technically difficult 
to interpret chest X-rays taken under such conditions, 
the findings were suggestive of a focus of infection in 
the right lung base (Figure 1). Because the information 
in the medical chart of the patient had been constantly 
updated, it was possible to compare the results of the 
arterial blood gas analysis performed at admission with 
those of that performed in 2004. 
The patient underwent aggressive hydration 
with saline solution. She was diagnosed with 
pneumonia (a PORT score of 236, risk class V) 
and exacerbation of chronic obstructive pulmonary 
disease. She was started on empirical treatment 
with 2 g/day of ceftriaxone. On the following day, 
clarithromycin (500 mg every 12 hours) was added. 
Her level of consciousness improved, as did her renal 
function and leukocyte count. 
DISCUSSION
An acute phase protein, CRP is generally 
found at high levels during inflammatory processes 
of various etiologies, including those of an infectious, 
autoimmune, or traumatic nature. The protein was 
first described in 1930, having been isolated from 
the serum of patients with bacterial pneumonia.1 
The physiological role of CRP is related to the ability 
of the protein to bind to cell wall components of 
various microorganisms, thus activating the classical 
complement pathway, acting as an opsonin and 
promoting phagocytosis.2,3 
The determination of serum CRP levels has 
recently been described as playing a role in the 
treatment of intensive care unit patients with septic 
Table 1 – Laboratory tests performed in the 
Emergency Department
Laboratory test Results Reference Value 
Hemoglobin 11.0 12.3-15.3 g/dl
Hematocrit 32 36.0-45.0 %
Mean  
corpuscular 
volume 
90 80 -96 fl
Mean 
corpuscular 
hemoglobin 
31 27.5-33.2 pg
White blood cells 14.7. 10³ 4.4-11.3 . 10³/mm³
 Bands 
 Segmented 
neutrophils 
10
88
1-5(%)
45 -70 (%)
Platelets 147. 10³ 150-400 . 10³  
(/mm³)
Urea 105 10-50 (mg/dl)
Creatinin 1.0 0.4-1.3 (mg/dl)
Sodium 126 135-146 (mEq/l)
Potassium 4.6 3.5 -5.0(mEq/l)
Ionized calcium 0.96 1.1-1.4 (mmol/l)
Aspartate 
aminotransferase 
21 10-35 (U/l)
Alanine 
aminotransferase 
13 9-43 (U/l)
Prothrombin time 
(International 
Normalized  
Ratio – INR) 
1.04 1
Urinalysis pH= 5.5
6,000  
leukocytes/ml
1,000  
erythrocytes/ml
4.7-7.8
< 10000/mm³
< 10000 mm³
Arterial blood 
gases
(room air)
pH = 7.32
pO2 = 32 
pCO2 = 61 
Bicarbonate = 31 
Base Excess = +3.7
Arterial O2 sat = 66
7.34-7.44
75 -100 mmHg
35 -45 mmHg
22-26 mEq/l
-3-+2.3 mEq/l
95-98 %
C-reactive 
protein 
149 <5 (mg/l)
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shock4,5 and in the prognosis of cardiovascular 
diseases (when high-sensitivity CRP is assessed),6,7 
as well as being a prognostic and diagnostic marker in 
patients with specific infectious diseases. The use of 
CRP testing in the follow-up of patients with infectious 
diseases outside the intensive care setting has yet to 
be standardized. Although the single determination of 
serum CRP levels is unexpensive, its indiscriminate 
use results in high costs, which is why standardization 
is required. 
The Situation at the USPUH
The USPUH is a community hospital that 
is dedicated to the care of Butantã residents, USP 
staff, and USP students. In recent years, the number 
of requests for determination of serum CRP levels 
in the USPUH, more specifically in the emergency 
department and in the clinical ward, has increased 
considerably. This increase was not accompanied 
by a proportional increase in the number of consults 
and hospitalizations. 
The estimated cost of the reagent for each 
CRP test in the USPUH is R$9.22 (approximately 
US$5.00). Taking into account the costs related to 
the repetition of the test in cases of abnormal results, 
as well as those related to materials and others, the 
annual cost of the determination of serum CRP levels 
is approximately R$330,000.00 (US$185,000.00). 
Figure 1 – Chest X-Ray showing heterogeneous opacity in right lung base and right costophrenic angle 
blurring, compatible with pneumonia.
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Here, we present a discussion of two studies 
that aimed at establishing the potential impact of the 
determination of serum CRP levels on the evaluation 
and treatment of patients suspected of having acute 
community-acquired infection. We also revisit certain 
clinical epidemiology concepts, which are required 
in order to interpret the results. 
Highlights of our Review of the Literature on 
the use of CRP as a Marker of Inflammation 
for Patients in the Emergency Department 
Study no. 1 - Prognostic value of mortality in 
emergency department sepsis score, procalcitonin, 
and C-reactive protein in patients with sepsis at the 
emergency department8. 
That study compared the relationship between 
early mortality (0–5 days) and late mortality (6–30 
days) of patients with sepsis initially evaluated in 
the emergency department. Three different tests, 
performed at admission to the emergency department, 
were compared:
– determination of serum CRP levels; 
– determination of serum procalcitonin levels;
– Mortality in Emergency Department Sepsis 
(MEDS) score9, a clinical and laboratory 
scoring system (Table 2).
It is clear that the major part of the score 
(and therefore the greatest weight) is attributed to 
anamnesis and clinical examination. In addition, the 
laboratory tests employed (blood workup and, in 
the presence of signs of respiratory infection, chest 
X-rays) are those that are habitually ordered in order 
to evaluate patients with sepsis.
The authors determined the cut-off point that 
was most accurate for each of the three evaluations. 
Sensitivity and specificity values (described below) 
were used in that study in order to calculate positive 
and negative likelihood ratios (LR+ and LR–, 
respectively). 
The LR+ expresses how many times a positive 
result of a given test is more likely to be found in 
individuals with a given disease than in those without 
it. The ratio between true positives and false positives 
is therefore calculated. The LR– expresses how many 
times a negative result of a given test is more likely 
to be found in individuals with a given disease (false 
negatives) than in those without it. Similarly, the 
ratio between false negatives and true negatives is 
calculated (Chart 1). 
For a test that is more frequently positive in 
patients with a given disease and more frequently 
negative in those without it, as is common in clinical 
practice, the LR+ is a number greater than 1 and 
the LR– is a number between 0 and 1. A greater 
distance from the number 1 translates to a greater 
impact of the test on the clinical reasoning (Chart 1). 
Table 2 – MEDS scoring system. Adapted form 
Lee et al.8
Clinical variable Score
Terminal illness 6
Tachypnea or hypoxia 3
Septic shock 3
Platelets  <150.000/mm3 3
Bands  >5% 3
Age  >65 anos 3
Low respiratory tract infection 2
Nursing home resident 2
Altered mental status 2
Total 27
Chart 1 – How to calculate LR+, LR– and how to 
interpret test results. Adapted from Hatanaka.10
How to calculate LR+:
Probability of positive test in individuals with disease
Probability of positive test in individuals without disease
How to calculate LR–:
Probability of negative test in individuals with disease
Probability of negative test in individuals without disease
LR >10.0 or LR< 0.1
Very good test, almost always impacts on clinical judgement
LR 5.0-10.0 or 0.1-0.2
Intermediate test value, can impact on clinical judgement
LR 2.0-5.0 or 0.2-0.5
Weak test, seldom changes clinical judgement
LR 0.5-2.0
Test is incapable of changing clinical judgement, it must not 
be performed’
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In clinical epidemiology terms, a greater distance 
between the LR and the number 1 translates to a 
greater impact of that result on the likelihood that the 
patient will have the disease (post-test probability). 
Fagan’s nomogram is used in order to illustrate this 
concept, as in our Figure 2. The figure shows the 
case of a patient who, before the test, has a 10% 
chance of having the disease (pre-test probability). 
If that patient undergoes a diagnostic test with a LR+ 
of 1.5, which confirms that result, the probability of 
having the disease increases to approximately 14%. 
However, if the patient undergoes a test with a LR+ 
of 5 or 15, the post-test probability is 35.7 and 62.5%, 
respectively. 
Let us return to study no. 18 in order to 
analyze the results of the comparison between the 
determination of serum CRP levels and the MEDS 
score in terms of their performance (Table 3). The 
determination of serum CRP levels is clearly inferior 
to the use of the MEDS score. The CRP-related PLR 
for early mortality has little influence on the evaluation 
of disease severity. More specifically, a high MEDS 
score at admission to the emergency department 
constitutes a far stronger indicator of disease severity 
and risk of death than do high serum CRP levels.
Study no. 2 -  Diagnostic value of C reactive 
protein in infections of the lower respiratory tract: 
systematic review.11 
Study no. 2, published in the British Medical 
Journal, presents the results of a systematic review 
of the literature evaluating the diagnostic accuracy 
of CRP testing in detecting radiologically proved 
pneumonia, as well as the extent to which the CRP 
test results can allow the reader to differentiate 
between viral and bacterial infections of the lower 
respiratory tract. Regarding the diagnostic accuracy 
of CRP testing in detecting radiologically proven 
pneumonia, the authors found six studies, a total 
Table 3 – C-reactive protein determination and MEDS score performances to predict early (0–5 days) and 
late (6–30 days) mortality in sepsis. Adapted form Lee et al.8
Early Mortality (0–5 days) Best cut-off value Sensitivity Specificity LR+ LR–
C-reactive protein >70 mg.dL–1 73% 63% 1.97 0.43
MEDS score >9 52% 93% 7.43 0.52
Late Mortality (6–30 days) Best cut-off value Sensitivity Specificity LR+ LR–
C-reactive protein >60 mg.dL–1 64% 58% 1.52 0.62
MEDS score >8 46% 91% 5.11 0.59
Figure 2 – Fagan’s nomogram. Lines indicate the 
impact of three tests, with LRs of 1.5 (green), 5.0 
(blue) and 15.0 (yellow), on disease probability of a 
person with a 10% pretest probability.
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of 1,178 patients having been evaluated. The 
determination of CRP levels has little impact on the 
clinical reasoning involved in the interpretation of 
infiltration seen on X-rays. For a cut-off point of 20 mg.
dL–1 (the point of highest accuracy), the CRP test LR+ 
(2.86), LR– (0.28), sensitivity (80%), and specificity 
(72%) were shown to have little impact on clinical 
practice, and decisions based on those results might 
lead to errors in a significant number of cases. 
Eight studies were deemed appropriate to 
evaluate whether CRP was able to differentiate 
between viral and bacterial infections of the lower 
respiratory tract. 
The studies in  quest ion were qui te 
heterogeneous in terms of methodology. 
The authors concluded that “the current 
evidence does not consistently and sufficiently support 
a wide introduction of CRP as a rapid test to guide 
antibiotics prescription”. 
FINAL CONSIDERATIONS
In the clinical case reported here, as occurs in 
many others, the determination of serum CRP levels 
did not aid in estimating the severity of the condition 
of the patient or in selecting medical approaches to 
management. It is of note that neither the decisions 
that were made nor the outcome would have changed 
had the test not been ordered. 
Requests for unnecessary tests result in 
material and human costs. It is important to maximize 
efforts to avoid such costs. The responsibility is 
even greater in the context of a teaching hospital. In 
addition, the possibility of making decisions based 
on the result of a laboratory test while there is still 
insufficient scientific evidence to support its use is a 
cause for concern. This evidence-based reasoning 
is quite common when selecting the therapeutic 
approach to a given patient. However, for some 
reason, the decision regarding which laboratory tests 
should be ordered is not always evidence-based. It 
is incorrect to assume that, unlike the administration 
of drugs, ordering unnecessary tests is not harmful 
to patients. False-positive results, which are inherent 
to any ancillary test, can lead to invasive diagnostic 
strategies and incorrect treatments. 
In adults, CRP has certain well-established 
roles, such as in the outpatient follow-up treatment 
of connective tissue diseases and certain chronic 
infections. In the follow-up of patients with acute 
infections, CRP plays a potential role in intensive 
care patients, which is due to the multiple variables 
involved. Such patients are at risk of developing 
nosocomial infections, undergo multiple procedures, 
and are exposed to various factors that can worsen the 
clinical profile. Nevertheless, serum CRP levels can 
never be considered in isolation and can be normal 
even in patients with severe infection, especially at 
the early stages. 
For patients admitted to the emergency 
department or infirmary, where the objective is to 
diagnose and provide initial treatment for the infection, 
CRP has little impact on the clinical reasoning. The 
use of the test can even lead to a false sense of 
security and deprive patients with bacterial disease of 
the appropriate treatment. There is also no evidence 
to support the use of the test in patient follow-up. In 
addition, it is of note that the first-line treatment for 
the acute bacterial infections that are most common 
in clinical practice is likely to yield a favorable result. 
When this does not occur, clinical signs are generally 
sufficient to detect treatment failure. 
The data presented here underscore the 
need for coordinated efforts in order to rationalize 
the use of resources. In a teaching hospital, the 
attending physician has the responsibility of teaching 
medical students and residents the principles of good 
medical practice. This includes teaching the value of 
anamnesis and clinical examination in order to avoid 
submitting patients to unnecessary tests. 
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